Aspen Pharmacare Holdings Ltd Financials

Market Capitalization R76.19 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	17.31
Forward PE	8.13
Price to Sales TTM	R1.70
Price to Book MRQ	R89.77
Enterprise to Revenue	2.21
Enterprise to EBITDA	9.61

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2024-06-30
Most Recent Quarter	2024-06-30
Profit Margin	9.85%
Operating Margin	22.88%
Return on Assets TTM	4.06%
Return on Equity TTM	5.15%

Income Statement

Revenue TTM	R44,706,000,000
Revenue per Share TTM	R100.64
Quarterly Revenue Growth	9.30%
Gross Profit TTM	R19,454,000,000
EBITDA	R11,834,000,000
Net Income to Common TTM	R4,404,000,000
Diluted EPS TTM	R9.91
Quarterly Earnings Growth YoY	-18.20%

Balance Sheet

Total Cash MRQ	R11,766,000,000
Total Cash per Share MRQ	R27.77
Total Debt MRQ	R
Total Debt to Equity MRQ	42.96
Current Ratio MRQ	1.81
Book Value per Share MRQ	R191.04

Cash Flow

Operating Cash Flow TTM	R5,464,000,000
Levered Free Cash Flow TTM	R4,404,000,000

APN Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	444,232,992
Float Shares	288,497,461
Avg 10 Volume	786,089
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	19.38%
% Held by Institutions	64.75%

Stock Price Summary

Beta	0.58
Fifty Two Week Low	R16293.00
Fifty Two Week High	R25296.00
Fifty Two Week Change	-13.09%
Day 50 MA	R16960.50
Day 200 MA	R20580.44

Dividends and Splits

Forward Annual Dividend Rate	R3.59
Forward Annual Dividend Yield	2.13%
Trailing Annual Dividend Rate	R3.59
Trailing Annual Dividend Yield	0.02%
Payout Ratio	34.50%
Dividend Date
Ex Dividend Date	2024-09-18
Last Split Factor
Last Split Date	2016-04-19